Gerri Henwood
Chief Executive Officer chez BAUDAX BIO, INC.
Fortune : 25 $ au 31/03/2024
Profil
Gerri A.
Henwood founded IBAH, Inc. in 1985, where she worked as President & Chief Executive Officer from 1985 to 1999, Auxilium Pharmaceuticals LLC in 1999, where she worked as President & Chief Executive Officer from 1999 to 2006, Societal CDMO, Inc. in 2008, where she worked as Director from 2020 to 2022, and Malvern Consulting Group, Inc. in 2006, where she worked as President from 2006 to 2013.
Ms. Henwood also currently works at Garnet BioTherapeutics, Inc., as Chief Executive Officer, Baudax Bio, Inc., as President, Chief Executive Officer & Director from 2019, LZ Therapeutics, Inc., as Director, and La Salle Academy, as Trustee.
Ms. Henwood also formerly worked at Alkermes, Inc., as Independent Director from 2011 to 2015, MAP Pharmaceuticals LLC, as Independent Director from 2004 to 2013, Tetraphase Pharmaceuticals, Inc., as Independent Director from 2015 to 2020, Smith Kline & French Laboratories Ltd., as Group Director-Marketing, Alkermes Plc, as Independent Director from 2011 to 2015, Actinium Pharmaceuticals, Inc., as Chief Development Officer from 2012 to 2013, SCP Vitalife Partners, as Venture Partner, and Neumann University, as Trustee.
Ms. Henwood received her undergraduate degree from Neumann University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BAUDAX BIO INC
0,00% | 07/09/2023 | 1 911 ( 0,00% ) | 25 $ | 31/03/2024 |
Postes actifs de Gerri Henwood
| Sociétés | Poste | Début |
|---|---|---|
| BAUDAX BIO, INC. | Chief Executive Officer | 01/01/2019 |
| La Salle Academy | Director/Board Member | - |
LZ Therapeutics, Inc.
 LZ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LZ Therapeutics, Inc. develops novel differentiated products for the treatment of neurological disorders. It provides therapeutics to improve patient outcomes, including improved symptom control and potential disease modification. The company was founded by Jay S. Schneider in 2005 and is headquartered in Chester, PA. | Director/Board Member | - |
Garnet BioTherapeutics, Inc.
 Garnet BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Garnet BioTherapeutics, Inc. develops products that speed healing and reduce scarring after surgery or dermatologic procedures. It is a clinical stage regenerative medicine company that discovers, develops, and delivers new regenerative therapies by leveraging the intrinsic ability of adult somatic cells to repair, regenerate, and remodel tissue in acute and chronic disease settings. The firm's manufacturing and technology platform is a scalable GMP-compliant manufacturing process that can be applied to multiple cell types including adult bone marrow-derived stromal cells, smooth and skeletal muscle cells, dermal fibroblasts, chondrocytes, pre-adipocytes, and endothelial cells. The company was founded by Hubert J.P. Schoemaker on November 26, 2003 and is headquartered in Malvern, PA. | Chief Executive Officer | - |
Anciens postes connus de Gerri Henwood
| Sociétés | Poste | Fin |
|---|---|---|
| SOCIETAL CDMO, INC. | Founder | 18/01/2022 |
| TETRAPHASE PHARMACEUTICALS, INC. | Director/Board Member | 01/06/2020 |
| ALKERMES PLC | Director/Board Member | 07/03/2015 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Director/Board Member | 01/03/2015 |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | Corporate Officer/Principal | 18/04/2013 |
Formation de Gerri Henwood
| Neumann University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SOCIETAL CDMO, INC. | Health Technology |
| BAUDAX BIO, INC. | Health Technology |
| ALKERMES PLC | Health Technology |
| Entreprise privées | 11 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
| IBAH, Inc. | Commercial Services |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Health Technology |
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | Commercial Services |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
SCP Vitalife Partners
 SCP Vitalife Partners Investment ManagersFinance SCP Vitalife Partners (SCP Vitalife) is a venture capital firm founded in 2000 by Dr. Abraham Ludomirski and Wayne B. Weisman. The firm is headquartered in Malvern, Philadelphia with additional office in Israel. | Finance |
Malvern Consulting Group, Inc.
 Malvern Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Malvern Consulting Group, Inc. is engaged in pre-clinical, clinical, regulatory, quality, manufacturing, and packaging services. It also offers Medical Writing, Strategic Consulting and development services. The company was founded by Geraldine A. Henwood and is headquartered in Malvern, PA. | Commercial Services |
Garnet BioTherapeutics, Inc.
Garnet BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Garnet BioTherapeutics, Inc. develops products that speed healing and reduce scarring after surgery or dermatologic procedures. It is a clinical stage regenerative medicine company that discovers, develops, and delivers new regenerative therapies by leveraging the intrinsic ability of adult somatic cells to repair, regenerate, and remodel tissue in acute and chronic disease settings. The firm's manufacturing and technology platform is a scalable GMP-compliant manufacturing process that can be applied to multiple cell types including adult bone marrow-derived stromal cells, smooth and skeletal muscle cells, dermal fibroblasts, chondrocytes, pre-adipocytes, and endothelial cells. The company was founded by Hubert J.P. Schoemaker on November 26, 2003 and is headquartered in Malvern, PA. | Commercial Services |
Smith Kline & French Laboratories Ltd.
 Smith Kline & French Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Smith Kline & French Laboratories Ltd. manufactures pharmaceutical products. The company is headquartered in Brentford, the United Kingdom. | Health Technology |
LZ Therapeutics, Inc.
LZ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LZ Therapeutics, Inc. develops novel differentiated products for the treatment of neurological disorders. It provides therapeutics to improve patient outcomes, including improved symptom control and potential disease modification. The company was founded by Jay S. Schneider in 2005 and is headquartered in Chester, PA. | Health Technology |
